Literature DB >> 26613274

De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.

Yusuke Shimoda1, Toshiya Osanai1, Naoki Nakayama1, Satoshi Ushikoshi2, Masaaki Hokari1, Hideo Shichinohe1, Takeo Abumiya1, Ken Kazumata1, Kiyohiro Houkin1.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant systemic disorder characterized by the enlargement of capillaries, recurrent nosebleeds, and multiple arteriovenous malformations (AVMs). Although cerebral AVMs are traditionally considered to be congenital lesions, some reports have described de novo AVMs, which suggests that the authors believed them to be dynamic conditions. In this article, the authors describe the case of a 5-year-old boy with HHT in whom a de novo cerebral AVM was detected after a negative MRI result at 5 months. To the authors' knowledge, this is the first report of a de novo AVM in a patient with HHT. In patients with a family history of HHT, de novo AVMs are possible, even when no lesions are detected at the first screening. Therefore, regular screenings need to be performed, and the family should be informed that AVMs could still develop despite normal MRI results.

Entities:  

Keywords:  AVM = arteriovenous malformation; DSA = digital subtraction angiography; HHT = hereditary hemorrhagic telangiectasia; Rendu-Osler-Weber syndrome; VEGF = vascular endothelial growth factor; de novo arteriovenous malformation; hereditary hemorrhagic telangiectasia; vascular disorders

Mesh:

Substances:

Year:  2015        PMID: 26613274     DOI: 10.3171/2015.7.PEDS15245

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  8 in total

1.  The time frame of the brain AVM formation.

Authors:  Masaki Komiyama
Journal:  Interv Neuroradiol       Date:  2019-04-24       Impact factor: 1.610

2.  Review of de novo cerebral arteriovenous malformation: haemorrhage risk, treatment approaches and outcomes.

Authors:  Xianli Lv; Guihuai Wang
Journal:  Neuroradiol J       Date:  2018-02-22

3.  De novo intracranial arteriovenous malformation development after endovascular treatment for a pial arteriovenous fistula in capillary malformation-arteriovenous malformation syndrome.

Authors:  Bikei Ryu; Shinsuke Sato; Tatsuki Mochizuki; Tatsuya Inoue; Yoshikazu Okada; Yasunari Niimi
Journal:  Interv Neuroradiol       Date:  2020-07-07       Impact factor: 1.610

4.  De Novo Arteriovenous Malformation after Aneurysm Clipping.

Authors:  Satoka Shidoh; Masahito Kobayashi; Kazunori Akaji; Tadashige Kano; Yoshio Tanizaki; Ban Mihara
Journal:  NMC Case Rep J       Date:  2017-06-08

Review 5.  Recent Trends in Neuro-endovascular Treatment for Acute Ischemic Stroke, Cerebral Aneurysms, Carotid Stenosis, and Brain Arteriovenous Malformations.

Authors:  Yuji Matsumaru; Eiichi Ishikawa; Tetsuya Yamamoto; Akira Matsumura
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-05-01       Impact factor: 1.742

Review 6.  'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Authors:  Ioan Alexandru Florian; Lehel Beni; Vlad Moisoiu; Teodora Larisa Timis; Ioan Stefan Florian; Adrian Balașa; Ioana Berindan-Neagoe
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

Review 7.  Pathogenesis of Brain Arteriovenous Malformations.

Authors:  Masaki Komiyama
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-14       Impact factor: 1.742

8.  Significant Hematochezia and Intracranial Bleeding in Neonatal Hereditary Hemorrhagic Telangiectasia.

Authors:  Matthew Merves; Kimberly Parsons; Adina Alazraki; Jonathan Meisel; Cary Sauer; Hong Li
Journal:  AJP Rep       Date:  2019-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.